SUPRIYA LIFESCIENCE
Back to Balance Sheet
|
SUPRIYA LIFESCIENCE Last 5 Year Contingent Liabilities History
[Standalone]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹4.17 Cr | ₹3.46 Cr | ₹5.62 Cr | ₹5.62 Cr | ₹1.57 Cr |
What is the latest Contingent Liabilities ratio of SUPRIYA LIFESCIENCE ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹4.17 Cr |
| Mar2024 | ₹3.46 Cr |
| Mar2023 | ₹5.62 Cr |
| Mar2022 | ₹5.62 Cr |
| Mar2021 | ₹1.57 Cr |
How is Contingent Liabilities of SUPRIYA LIFESCIENCE Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹4.17 Cr | 20.41 | |
| Mar2024 | ₹3.46 Cr | -38.45 | |
| Mar2023 | ₹5.62 Cr | 0.00 | |
| Mar2022 | ₹5.62 Cr | 257.96 | |
| Mar2021 | ₹1.57 Cr | - | |
Compare Contingent Liabilities of peers of SUPRIYA LIFESCIENCE
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUPRIYA LIFESCIENCE | ₹5,135.5 Cr | 3.5% | 9.8% | -20.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹397,018.0 Cr | -2.3% | -8.5% | -3% | Stock Analytics | |
| DIVIS LABORATORIES | ₹162,454.0 Cr | 5.3% | -3.4% | 3.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹140,702.0 Cr | 3.7% | -4.9% | 26% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹102,830.0 Cr | 1.2% | -4.2% | 5.3% | Stock Analytics | |
| CIPLA | ₹99,325.0 Cr | 2.4% | -7.2% | -18.1% | Stock Analytics | |
SUPRIYA LIFESCIENCE Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUPRIYA LIFESCIENCE | 3.5% |
9.8% |
-20.8% |
| SENSEX | 5.8% |
-1.7% |
1.2% |
You may also like the below Video Courses